TKI-based regimens were associated with higher rates of disease control in metastatic translocation renal cell carcinoma.
|Videos|May 25, 2017
Dr. Badani on the Benefits of Robotic Surgery for Kidney Cancer
Author(s)Ketan K. Badani, MD
Ketan K. Badani, MD, professor of Urology at Mount Sinai Hospital, discusses the benefits of performing a partial robotic nephrectomy for patients with kidney cancer.
Advertisement
Ketan K. Badani, MD, professor of Urology at Mount Sinai Hospital, discusses the benefits of performing a partial robotic nephrectomy for patients with kidney cancer.
Having a minimally invasive surgery gives patients a quicker recovery time with less pain involved, explains Badani.
Additionally, the surgery is able to protect normal kidney function, which benefits the kidney over a longer period of time, states Badani.
Advertisement
Related to this article
David R. Gandara, MD, discusses why PD-L1 scoring in NSCLC undercounts immunotherapy benefit and where TMB and plasma proteomics fit alongside it.
Edgardo S. Santos Castillero, MD, discusses MAVERICK, B7-H3 ADC data, and tarlatamab sequencing in SCLC, plus molecular testing in a value-based practice.
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer
2
Tumor-Reactive TIL and UMIS Biomarker Predict Response in Metastatic Uveal Melanoma
3
EU Approval Reccomended by CHMP for Senaparib in First-Line Advanced Ovarian Cancer
4
CHMP Recommends Adjuvant T-DXd for HER2+ Early Breast Cancer With Residual Invasive Disease
5